Fascin inhibitors are a class of chemical compounds that specifically target and inhibit the activity of fascin, an actin-bundling protein crucial in the formation of cellular protrusions such as filopodia. Filopodia are slender, actin-rich extensions from the cell surface that play significant roles in cell motility, adhesion, and environmental sensing. Fascin, by cross-linking actin filaments, organizes them into tight, parallel bundles, thereby stabilizing these structures. The precise regulation of fascin is fundamental to the dynamic reorganization of the cytoskeleton, enabling cells to interact with their surroundings and migrate. Inhibition of fascin disrupts the formation and stabilization of filopodia, leading to altered cellular architecture and impaired movement. Fascin inhibitors typically bind to fascin directly, preventing it from interacting with actin filaments and impeding its bundling activity. These compounds often feature molecular structures that allow them to target specific fascin-actin interaction sites, thereby disrupting the delicate balance of forces that stabilize actin filaments within filopodia.
The development and study of fascin inhibitors have provided important insights into the molecular mechanisms governing actin dynamics and cellular movement. By blocking fascin's actin-bundling capabilities, these inhibitors serve as useful tools for studying cellular processes that depend on actin-rich protrusions, such as cell migration and morphogenesis. Fascin inhibitors are of particular interest in research focused on understanding how cells change shape and navigate their environment. Their application has furthered our understanding of the relationship between actin organization and cellular behaviors, offering new avenues to explore the fundamental principles of cytoskeletal regulation. Additionally, fascin inhibitors have helped illuminate the distinct roles that fascin plays in various cellular environments, leading to a more comprehensive understanding of how actin-bundling proteins contribute to the structural integrity and dynamic behavior of cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is known to specifically inhibit histone deacetylase, leading to hyperacetylation of histones, which could downregulate Fascin expression by altering gene transcription processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine can cause DNA demethylation, which might lead to the reactivation of silenced genes and a consequent decrease in Fascin expression levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may direct cell differentiation and proliferation pathways that lead to the downregulation of Fascin expression through retinoic acid receptors and their interaction with DNA. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could disrupt transcription factors that specifically promote Fascin expression, leading to a decrease in its levels, based on its known interactions with multiple cellular pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may downregulate Fascin expression by hindering the activation of certain transcription factors or by initiating cellular pathways that lead to the reduction of Fascin mRNA transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY 294002 could lead to reduced phosphorylation of AKT, which is crucial for the expression of Fascin, thereby decreasing its protein expression levels. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 specifically inhibits ROCK kinase activity, which could lead to decreased Fascin expression by destabilizing actin structures that are necessary for Fascin's role in cell motility. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, as an MEK inhibitor, might specifically downregulate Fascin by inhibiting the MAPK/ERK pathway, which is closely linked to the control of gene expression responsible for cell migration and proliferation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 specifically targets p38 MAPK, potentially leading to a decrease in Fascin expression by altering the cellular stress response pathways that include gene expression control. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a specific inhibitor of JNK, which may lead to a decrease in Fascin expression by influencing the JNK signaling pathway that regulates gene expression related to cytoskeletal organization. | ||||||